Back
Kura Oncology Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
16
KURA
Kura Oncology
Last Price:
10.73
Seasonality Move:
11.8%
Buy
79
PLX
Protalix BioTherapeutics
Last Price:
1.69
Seasonality Move:
86.81%
Sell
16
Kura Oncology (KURA)
is a Sell
Is Kura Oncology a Buy, Sell or Hold?
- The current Kura Oncology [KURA] share price is $10.96. The Score for KURA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- KURA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
79
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.71. The Score for PLX is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KURA Stock Price Chart
What is Kura Oncology's stock price today?
-
The Kura Oncology share price today is $10.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KURA is experiencing slight selling pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.71
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight buying pressure.
KURA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.59 | Sell |
| Relative Strength Index (14 RSI): | 23.01 | Sell |
| Chaikin Money Flow: | -331407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.15 - 18.65) | Sell |
| Bollinger Bands (100): | (16.87 - 21.13) | Sell |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 74.9 | Buy |
| Chaikin Money Flow: | 65591 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.09 - 1.53) | Buy |
| Bollinger Bands (100): | (0.94 - 1.28) | Buy |
KURA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.02 | Sell |
| 20-day SMA: | 16.13 | Sell |
| 50-day SMA: | 17.73 | Sell |
| 200-day SMA: | 19.89 | Sell |
| 8-day EMA: | 13.43 | Sell |
| 20-day EMA: | 15.43 | Sell |
| 50-day EMA: | 17.18 | Sell |
| 200-day EMA: | 18.22 | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.61 | Buy |
| 20-day SMA: | 1.37 | Buy |
| 50-day SMA: | 1.19 | Buy |
| 200-day SMA: | 1.19 | Buy |
| 8-day EMA: | 1.6 | Buy |
| 20-day EMA: | 1.42 | Buy |
| 50-day EMA: | 1.26 | Buy |
| 200-day EMA: | 1.24 | Buy |
Kura Oncology Earnings Growth & KURA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.50 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kura Oncology Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||